Craig M. Greven
Directeur Technique/Scientifique/R&D chez OcuCure Therapeutics, Inc.
Profil
Craig M.
Greven is Chief Medical Officer of OcuCure Therapeutics, Inc. He is Chairman of the Department of Ophthalmology at the Wake Forest University Eye Center.
Dr. Greven received an MD from the Bowman Gray School of Medicine.
Postes actifs de Craig M. Greven
| Sociétés | Poste | Début |
|---|---|---|
OcuCure Therapeutics, Inc.
 OcuCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuCure Therapeutics, Inc. discovers and develops drugs. It develops technologies to reduce and prevent vision loss caused by eye diseases. The firm provides drugs for treatment of age-related macular degeneration that inhibit new blood vessels from sprouting and causes regression of partially grown blood vessels. The company was founded in 2005 and is headquartered in Roanoke, VA. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Craig M. Greven
| Sociétés | Poste | Fin |
|---|---|---|
| Wake Forest University | Corporate Officer/Principal | - |
Formation de Craig M. Greven
| Wake Forest University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
OcuCure Therapeutics, Inc.
OcuCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuCure Therapeutics, Inc. discovers and develops drugs. It develops technologies to reduce and prevent vision loss caused by eye diseases. The firm provides drugs for treatment of age-related macular degeneration that inhibit new blood vessels from sprouting and causes regression of partially grown blood vessels. The company was founded in 2005 and is headquartered in Roanoke, VA. | Health Technology |
